Prosecution Insights
Last updated: August 06, 2026

Porter Wright Morris & Arthur, LLP

32 pending office actions • 20 clients • 29 examiners • 22 art units • 0 of 32 (0%) have an AI response strategy ready

Quality Metrics (n=1819 apps, methodology: how we score firms)

85.3%
Allowance Rate
n=1819
+0.71σ
Allowance Rate (norm)
n=1819
3.4
OAs to Allowance
n=1221
-0.15σ
OAs to Allow (norm)
n=1221
1181 days
Time to Allowance
n=1221
+6.9pp
Interview Lift
n=1819
27.6%
RCE Rate
n=1819
2.1%
Appeal Rate
n=1819

Rejection Performance (% of received rejections ultimately overcome)

79.7%
§101 Overcome
n=148
80.9%
§102 Overcome
n=466
82.1%
§103 Overcome
n=806
82.6%
§112 Overcome
n=650

Specialization & Scale

A61K, G01N, A61P
Top CPC Subclasses
16%
Top-3 CPC Share
n=1819
0
Practitioners
n=1819
Apps / Practitioner
n=1819 (min 20)

Portfolio Summary

32
Total Pending OAs
18
Non-Final OAs
14
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

8
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (8)Due ≤ 30 days (2)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

16
Hard (50%)
11
Medium (34%)
5
Easy (16%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (6%)
§101 + other2 (6%)
§103 only10 (31%)
§102 only1 (3%)
§112 only4 (12%)
Double-patenting only1 (3%)
Multi-statute (no §101)12 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

25
Life Sciences
78% of docket
1
Information Tech
3% of docket
0
Communications
0% of docket
1
Semiconductors
3% of docket
2
Mechanical / Eng
6% of docket
3
Business / Other
9% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

320 h
Manual time on pending OAs
64 h
Time saved (low, 20%)
112 h
Time saved (mid, 35%)
2.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KRAISINGER, EMILY MARIE 2 31.1% +44.0%
HERON, VELVET ELIZABETH 2 42.9% +57.8%
BAKSHI, PANCHAM 2 77.0% +30.2%
DEERY, ERIN LEAH 1 58.4% +49.0%
WRUBLESKI, MATTHEW JAMES 1 59.8% +59.4%
AMICK, THOMAS RUSSE 1 72.6% +31.1%
SODERQUIST, ARLEN 1 59.8% +26.5%
VALLE, ERNESTO 1 56.0% +41.3%
OLSON, ANDREA STEFFEL 1 62.2% -11.9%
LUSI, ELLIS FOLLETT 1 64.3% +52.8%

Hard Cases (16)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18002537 Blood Sampling Device and Method for PEth Measurement HERON, VELVET ELIZABETH 46d overdue
18554006 TREATMENT OF VIRUS INFECTIONS OLSON, ANDREA STEFFEL 32d overdue
18246569 TREATMENT OF MUSCLE ATROPHY USING DEXTRAN SULFATE BAKSHI, PANCHAM 32d overdue
18005757 METHODS AND COMPOSITIONS FOR TREATMENT OF FRAGILE X SYNDROME BATES, KEENAN ALEXANDER 23d
19061380 Toilet Training Seat DEERY, ERIN LEAH
18953885 LANGUAGE MODEL-ASSISTED CONTENT COMPLIANCE ANALYSIS SYSTEM KRAISINGER, EMILY MARIE
18953799 AUTOMATED COMPLIANCE VERIFICATION OF REGULATED CONTENT ITEMS IN A CONTENT PAGE KRAISINGER, EMILY MARIE
18577441 IMPROVEMENTS IN OR RELATING TO A METHOD OR AN APPARATUS FOR DETECTING AN INTERACTION BETWEEN A BIOLOGICAL ENTITY AND A MOLECULE SODERQUIST, ARLEN

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18002537 Blood Sampling Device and Method for PEth Measurement HERON, VELVET ELIZABETH 46d overdue
18246569 TREATMENT OF MUSCLE ATROPHY USING DEXTRAN SULFATE BAKSHI, PANCHAM 32d overdue
19061380 Toilet Training Seat DEERY, ERIN LEAH
18953885 LANGUAGE MODEL-ASSISTED CONTENT COMPLIANCE ANALYSIS SYSTEM KRAISINGER, EMILY MARIE
18953799 AUTOMATED COMPLIANCE VERIFICATION OF REGULATED CONTENT ITEMS IN A CONTENT PAGE KRAISINGER, EMILY MARIE
18681294 TAMPON INSERTION DEVICE AND METHOD WRUBLESKI, MATTHEW JAMES
18578381 DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT AMICK, THOMAS RUSSE
18577441 IMPROVEMENTS IN OR RELATING TO A METHOD OR AN APPARATUS FOR DETECTING AN INTERACTION BETWEEN A BIOLOGICAL ENTITY AND A MOLECULE SODERQUIST, ARLEN

Client Portfolio (20 clients)

Top Art Units

Art UnitApps
16233
17983
17973
36262
16381
16931
16361
16631
17581
17741

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19061380 Toilet Training Seat Mykidzy LLC DEERY, ERIN LEAH §103§112 Non-Final OA Pending Feb 24, 2025
18953885 LANGUAGE MODEL-ASSISTED CONTENT COMPLIANCE ANALYSIS SYSTEM Complyauto Ip LLC KRAISINGER, EMILY MARIE 3626 §101 Final Rejection Pending Nov 20, 2024
18953799 AUTOMATED COMPLIANCE VERIFICATION OF REGULATED CONTENT ITEMS IN A CONTENT PAGE Complyauto Ip LLC KRAISINGER, EMILY MARIE 3626 §101§103 Final Rejection Pending Nov 20, 2024
18681294 TAMPON INSERTION DEVICE AND METHOD Tina Holdings, LLC WRUBLESKI, MATTHEW JAMES DP Non-Final OA Pending Feb 05, 2024
18578381 DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT Children'S Hospital Medical Center AMICK, THOMAS RUSSE 1638 §102 Non-Final OA Pending Jan 11, 2024
18577441 IMPROVEMENTS IN OR RELATING TO A METHOD OR AN APPARATUS FOR DETECTING AN INTERACTION BETWEEN A BIOLOGICAL ENTITY AND A MOLECULE Lightcast Discovery Ltd. SODERQUIST, ARLEN §102§103§112 Non-Final OA Pending Jan 08, 2024
18573570 NEW USE OF MONENSIN Marco Maccarana VALLE, ERNESTO 1623 §102§103§112 Non-Final OA Pending Dec 22, 2023
18554006 TREATMENT OF VIRUS INFECTIONS Tx Medic AB OLSON, ANDREA STEFFEL 1693 §103§112 Non-Final OA 32d overdue Pending Oct 05, 2023
18282396 METHOD OF SELECTING CELLS Lightcast Discovery Ltd. LUSI, ELLIS FOLLETT 1636 §112 Non-Final OA Pending Sep 15, 2023
18263146 METHOD OF PROVIDING BROAD-SPECTRUM RESISTANCE TO PLANTS, AND PLANTS THUS OBTAINED Naga Charan Konakalla ORDAZ, CHRISTIAN JOSE 1663 §112 Final Rejection 97d overdue Pending Jul 27, 2023
18252813 REFINED USES OF GABA A RECEPTOR MODULATORS IN TREATMENT OF FRAGILE X SYNDROME Children'S Hospital Medical Center WHITE, DENNIS MICHAEL 1758 §102§103Other Final Rejection Pending May 12, 2023
18030136 IMPROVEMENTS IN OR RELATING TO A DEVICE AND METHODS FOR FACILITATING MANIPULATION OF MICRODROPLETS Lightcast Discovery Ltd. HERON, VELVET ELIZABETH 1798 §102§103 Final Rejection Pending Apr 04, 2023
18030132 IMPROVEMENTS IN OR RELATING TO A DEVICE AND METHODS FOR FACILITATING MANIPULATION OF MICRODROPLETS Lightcast Discovery Ltd. MUI, CHRISTINE T 1797 §103§112 Final Rejection Pending Apr 04, 2023
18246569 TREATMENT OF MUSCLE ATROPHY USING DEXTRAN SULFATE Tx Medic AB BAKSHI, PANCHAM 1623 §102§103§112Other Non-Final OA 32d overdue Pending Mar 24, 2023
18109074 SYSTEM FOR SYSTEM FOR PREPARING HIGH-PURITY TAURINE AND SALT Qianjiang Yongan Pharmaceutical Co. Ltd. KUYKENDALL, ALYSSA LEE 1774 §103 Non-Final OA 79d overdue Pending Feb 13, 2023
18040074 CALCIUM-DEFICIENT SILICATE-SUBSTITUTED CALCIUM PHOSPHATE APATITE COMPOSITIONS AND METHODS Ossdsign AB LIU, TRACY 1614 §103 Non-Final OA 70d Pending Jan 31, 2023
18006745 PREDICTING CANCER RELAPSE AND TREATMENT OF CANCER DISEASES Fredrik Johansson Swartling KOVACH, KARA NICOLE 1681 §103 Final Rejection 41d Pending Jan 25, 2023
18005757 METHODS AND COMPOSITIONS FOR TREATMENT OF FRAGILE X SYNDROME Forge Biologics, Inc. BATES, KEENAN ALEXANDER 1631 §102§103 Non-Final OA 23d Pending Jan 17, 2023
18002537 Blood Sampling Device and Method for PEth Measurement Capitainer AB HERON, VELVET ELIZABETH 1798 §102§103 Non-Final OA 46d overdue Pending Dec 20, 2022
18002526 Functionalized Blood Sampling Device and Method for PEth Measurement Capitainer AB GZYBOWSKI, MICHAEL STANLEY 1798 §103 Final Rejection 147d overdue Pending Dec 20, 2022
18067211 SENSOR UNIT, MEASURING METHOD AND PRODUCTION METHOD Presens Precision Sensing GmbH GERIDO, DWAN A 1797 §102§103§112 Non-Final OA Pending Dec 16, 2022
17958287 SYSTEM AND METHOD TO ENGINEER USER EXPERIENCE Cigniti Technologies Limited MORSHED, HOSSAIN M 2191 §101 Final Rejection Pending Sep 30, 2022
17794286 PREDICTING PATIENT SURVIVAL Arocell AB DUNN, MCKENZIE A 1678 §103 Non-Final OA Pending Jul 21, 2022
17858296 MICROFLUIDIC DEVICES Capitainer AB GERHARD, ALISON CLAIRE 1797 §103 Non-Final OA Pending Jul 06, 2022
17785455 PLATELET CONCENTRATE CONTROL Cyteguard AB CHOWDHURY, TARIFUR RASHID 2877 §103 Final Rejection Pending Jun 15, 2022
17776644 PEG-LIPID Icoat Medical AB BAKSHI, PANCHAM 1623 §103 Non-Final OA Pending May 13, 2022
17767730 METHOD AND APPARATUS FOR CLINICAL TESTING Lightcast Discovery Ltd. AFREMOVA, VERA 1653 §103§112 Non-Final OA Pending Apr 08, 2022
17642510 IN VITRO FERTILISATION (IVF) EMBRYO VIABILITY AND QUALITY ASSAY UNIVERSITY OF TARTU BAUSCH, SARAE L 1699 §101§102§112 Final Rejection Pending Mar 11, 2022
17625527 NOVEL BSSL ANTIBODIES Lipum AB AEDER, SEAN E 1642 §112 Non-Final OA 23d overdue Pending Jan 07, 2022
17603774 VIRAL VECTOR MANUFACTURING METHODS Children'S Hospital Medical Center JADHAO, SAMADHAN JAISING 1672 §103Other Final Rejection 8d Pending Oct 14, 2021
17432656 METHODS AND COMPOSITIONS FOR THE DETECTION, CLASSIFICATION, AND DIAGNOSIS OF CHRONIC POST-SURGICAL PAIN Children'S Hospital Medical Center SISSON, BRADLEY L 1682 §112 Final Rejection 15d overdue Pending Aug 20, 2021
17297112 EX VIVO ORGAN TREATMENT WITH PEG-PHOSPHOLIPID MOLECULES Icoat Medical AB BEHARRY, ZANNA MARIA 1632 §103 Final Rejection Pending May 26, 2021

Managing Porter Wright Morris & Arthur, LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month